Using vaginal estrogen tablets was not associated with an increased risk of recurrent ischemic stroke among postmenopausal women in a registry in Denmark, according to research published in Stroke.

The reason cited for the pull from market suggests a possible lack of effectiveness.

Exeltis USA, Inc. (Exeltis), a global pharmaceutical company specializing in women’s health, announced that the U.S. Food and ...

Stroke survivors often face tough choices about managing menopause symptoms. A new study from Copenhagen University Hospital–Herlev and Gentofte found that vaginal estrogen tablets were not linked to ...

A total of 3353 recurrent cases were identified from a cohort of 56,642 women with a first-time stroke and were matched with 3353 controls. HealthDay News — For women with a history of ischemic stroke ...

Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 2008;111:67 ...

Alexis Dunne always plans how to best treat her patients’ perimenopause and menopause symptoms. The Chicago-area physician wants to ensure that the hormone replacement therapy she prescribes helps ...

Please provide your email address to receive an email when new articles are posted on . Postmenopausal women with moderate to severe genitourinary syndrome experienced small but significant increases ...

Researchers saw no link between vaginal estrogen therapy and recurrent strokes, despite concerns that the hormone is systemically absorbed. In a case-control study of female stroke survivors across ...

BAUDETTE, Minn., Sept. 12, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for ...

Hormone replacement therapy using vaginal estrogen tablets was not associated with an increased risk of ischemic stroke for postmenopausal women who have already had a stroke, according to a data ...